{"id":8158,"date":"2023-08-29T07:35:00","date_gmt":"2023-08-29T07:35:00","guid":{"rendered":"https:\/\/www.acarix.com\/first-veterans-affairs-healthcare-system-standardizes-use-of-acarix-cadscor-system-2\/"},"modified":"2024-11-18T19:04:55","modified_gmt":"2024-11-18T19:04:55","slug":"first-veterans-affairs-healthcare-system-standardizes-use-of-acarix-cadscor-system-2","status":"publish","type":"post","link":"https:\/\/d.ptpl.dev\/acarix\/first-veterans-affairs-healthcare-system-standardizes-use-of-acarix-cadscor-system-2\/","title":{"rendered":"First Veterans Affairs Healthcare System Standardizes Use of Acarix CADScor System"},"content":{"rendered":"
\n

Acarix, a leader in acoustic and AI-based cardiac diagnostics, today announces a significant advancement in the utilization of its CADScor System within the Veterans Administration (VA) Healthcare network, the largest healthcare provider in the US. The Southeast Louisiana VA Healthcare System has now approved and adopted the CADScor System into its Standard Operating Procedure (SOP) for risk-stratification of symptomatic patients suspected of coronary artery disease (CAD). Furthermore, an additional VA hospital – Biloxi VA Medical Center (VA Gulf Coast Veterans Healthcare System) has placed an initial order for the CADScor System and its single use patches.<\/strong><\/p>\n<\/div>\n

\n

The Southeast Louisiana VA healthcare system was the first VA location to place orders for CADScor System and patches in February. Approval of the CADScor System into their SOP signifies an important step in securing the routine use and adoption of the CADScor System as standard of care for symptomatic patients suspected of coronary artery disease.<\/p>\n

In June, Acarix expanded its presence in the Southeast region with the additional order of CADScor System at the Biloxi Medical Center in the VA Gulf Coast Veterans Healthcare System, one of the leading healthcare systems serving Veterans in the Southcentral Region, covering medical centers and clinics in Mississippi, Louisiana, Arkansas, Oklahoma, Southeast Texas, and Northwest Florida.<\/p>\n

“Over the past few months, we have collaborated closely with the Acarix team and are in the process of implementing the 11 CADScor Systems across multiple sites within the Southeast Louisiana Veterans Health Care System,” stated Dr. Anand M. Irimpen, Chief, Cardiology Section. “Our teams are in the process of integrating the CADScor System into their workflow in line with the clinical workflow developed by Acarix in collaboration with the American College of Cardiology. This allows us to increase utilizing CADScor System as a first-line diagnostic aid to stratify risk for all patients who come into our facilities experiencing stable chest pain.”<\/p>\n

“Securing the inclusion of the CADScor System into the Southcentral VA Healthcare Network SOP constitutes another major milestone for Acarix as we grow our business at the VA, and in the US,” commented Helen Ljungdahl Round, President & CEO of Acarix. “Equitable access to high-quality care for all veterans is a major tenet of the VA healthcare mission. Incorporating the CADScor System routinely into the diagnostic workflow for symptomatic patients will help physicians meet their goals by ruling out significant coronary artery disease early in the diagnostic pathway and allowing attention on patients needing care.”<\/p>\n<\/div>\n

\n

For more information contact:<\/strong>
Helen Ljungdahl Round, CEO, phone +1 267 809 1225, +46 730 770283, email helen.round@acarix.com<\/a> 
Christian Lindholm, CFO, phone +46 705 118333, email christian.lindholm@acarix.com<\/a><\/p>\n<\/div>\n

\n

About Acarix<\/strong><\/p>\n\n\n\n
Acarix is a Swedish medical device company that innovates solutions for rapid AI-based rule out of Coronary Artery Disease (CAD). The CE approved and FDA DeNovo cleared Acarix CADScor®System is intended for patients experiencing chest pain with suspected CAD and designed to help reduce millions of unnecessary, invasive and costly diagnostic procedures. The CADScor System uses advanced acoustics and AI-technology to rule out CAD non-invasively in less than 10 minutes, with at least 96% certainty. Acarix is listed on the Nasdaq First North Premier Growth Market in Stockholm (ticker: ACARIX). Redeye AB (+46 8 121 576 90, certifiedadviser@redeye.se<\/a>) is Certified Advisor of Acarix. For more information, please visit www.acarix.com<\/a>. <\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n
\n

Attachments<\/strong>
First Veterans Affairs Healthcare System Standardizes Use of Acarix CADScor System<\/a><\/p>\n<\/div>\n